The effect of chronic antipsychotic treatment on sexual behaviour, hormones and organ size in the male rat

Journal of Psychopharmacology

Volumn 21, Issue 4, 2007, Pages 428-434

  Zhang, Xiangrong ^a   Zhang, Zhijun ^b   Cheng, Weirong ^a   Mou, Xiaodong ^b   Reynolds, Gavin P ^c  

^a NANJING MEDICAL UNIVERSITY   (China)

^b SOUTHEAST UNIVERSITY   (China)

^c QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

Antipsychotics; Genital organs; Sex hormones; Sexual dysfunction

Indexed keywords

HALOPERIDOL; LUTEINIZING HORMONE; NEUROLEPTIC AGENT; RISPERIDONE;

ANIMAL EXPERIMENT; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; EJACULATION; EPIDIDYMIS; ERECTILE DYSFUNCTION; FEMALE; LIBIDO; LUTEINIZING HORMONE BLOOD LEVEL; MALE; MOTIVATION; NONHUMAN; ORGAN SIZE; ORGAN WEIGHT; ORGASM; PRIORITY JOURNAL; PROSTATE; RAT; SEMINAL VESICLE; SEXUAL AROUSAL; SEXUAL BEHAVIOR; SEXUAL DYSFUNCTION; SEXUAL FUNCTION; TESTOSTERONE BLOOD LEVEL;

ANIMALS; ANTIPSYCHOTIC AGENTS; COPULATION; FEMALE; GENITALIA, MALE; HALOPERIDOL; LUTEINIZING HORMONE; MALE; ORGAN SIZE; RATS; RATS, SPRAGUE-DAWLEY; RISPERIDONE; SEXUAL BEHAVIOR, ANIMAL; TESTOSTERONE;

EID: 34447578752     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881106068702     Document Type: Article

References (46)

1. Archer S.L. (2002) Potassium channels and erectile dysfunction. Vascul Pharmacol 38: 61 - 71
2. Argiolas A., Melis M.R. (2003) The neurophysiology of the sexual cycle. J Endocrinol Invest 26 (S3). 20 - 22
3. Baldwin D., Mayers A. (2003) Sexual side-effects of antidepressant and antipsychotic drugs. Advances in Psychiatric Treatment 9: 202 - 210
4. Baptista T., Alastre T., Contreras Q., Martinez J.L., Araujo de Baptista E., Paez X., Hernandez L. (1997) Effects of the antipsychotic drug sulpiride on reproductive hormones in healthy men: relationship with body weight regulation. Pharmacopsychiatry 30: 250 - 255
5. Barnes T R E, Harvey C.A., (1993) Psychiatric drugs and sexuality. In Riley A J, Peet M, Wilson C (eds). Sexual Pharmacology. Oxford Medical Publications, Oxford: 176 - 196.
6. Bobes J., Garca-Portilla M.P., Rejas J., Hern Ndez G., Garcia-Garcia M., Rico-Villademoros F., Porras A. (2003) Frequency of sexual dysfunction and other reproductive side-effects in patients with schizophrenia treated with risperidone, olanzapine, quetiapine, or haloperidol: the results of the EIRE study. J Sex Marital Ther 29: 125 - 147
7. Brown A.S., Hembree W.C., Friedman J.H., Kaufmann C.A., Gorman J.M. (1995) The gonadal axis in men with schizophrenia. Psychiatry Res 57: 231 - 239
8. Compton M.T., Miller A.H. (2002) Antipsychotic-induced hyperprolactinemia and sexual dysfunction. Psychopharmacol Bull 36: 143 - 164
9. Coppenolle V.F., Slomianny C., Carpentier F., Le Bourhis X, Ahidouch A., Croix D., Legrand G., Dewailly E., Fournier S., Cousse H., Authie D., Raynaud J.P., Beauvillain J.C., Dupouy J.P., Prevarskaya N. (2001) Effects of hyperprolactinemia on rat prostate growth: evidence of androgeno-dependence. Am J Physiol Endocrinol Metab 280: E120 - 129
10. Cutler A.J. (2003) Sexual dysfunction and antipsychotic treatment. Psychoneuroendocrinology 28 (suppl.) 1: 69 - 82
11. Dohle G.R., Smit M., Weber R.F. (2003) Androgens and male fertility. World J Urol 21: 341 - 345
12. Dossenbach M., Erol A., el Mahfoud Kessaci M., Shaheen M.O., Sunbol M.M., Boland J., Hodge A., O'Halloran R.A., Bitter I., IC-SOHO Study Group (2004) Effectiveness of antipsychotic treatments for schizophrenia: interim 6-month analysis from a prospective observational study (IC-SOHO) comparing olanzapine, quetiapine, risperidone, and haloperidol. J Clin Psychiatry 65: 312 - 321
13. Du J., Hull E.M. (1999) Effects of testosterone on neuronal nitric oxide synthase and tyrosine hydroxylase. Brain Res 836: 90 - 98
14. Dunbar F., Kusumakar V., Daneman D., Schulz M. (2004) Growth and sexual maturation during long-term treatment with risperidone. Am J Psychiatry 161: 918 - 920
15. Finn S.E., Baily J.M., Schultz R.T., Faber R. (1990) Subjective utility ratings of neuroleptics in treating schizophrenia. Psychol Med 35: 843 - 848
16. Giuliano F., Rampin O. (2000) Central neural regulation of penile erection. Neurosci Biobehav Rev 24: 517 - 533
17. Halbreich U., Kahn L.S. (2003) Hormonal aspects of schizophrenias: an overview. Psychoneuroendocrinology 28 (suppl. 2). 1 - 16
18. Heaton J.P., Adams M.A. (2003) Update on central function relevant to sex: remodeling the basis of drug treatments for sex and the brain. Int J Impot Res. 15 (suppl. 5). S25 - 32
19. Hull E.M., Muschamp J.W., Sato S. (2004) Dopamine and serotonin: influences on male sexual behavior. Physiology and Behavior 83: 291 - 307
20. Hummer M., Kemmler G., Kurz M., Kurzhaler I., Oberbauer H., Fleischhacker W.W. (1999) Sexual disturbances during clozapine and haloperidol treatment for schizophrenia. Am J Psychiat 4: 631 - 633
21. Kaneda Y. (2001) Risperidone-induced ejaculatory dysfunction: a case report. Eur Psychiatry 16: 134 - 135
22. Kaneda Y., Fujii A. (2000) Effects of chronic neuroleptic administration on the hypothalamo-pituitary-gonadal axis of male schizophrenics. Prog Neuropsychopharmacol Biol Psychiatry 24: 251 - 258
23. Kaneda Y., Fujii A., Ohmori T. (2002) The hypothalamic-pituitary-adrenal axis in chronic schizophrenic patients long-term treated with euroleptics. Prog Neuropsychopharmacol Biol Psychiatry 26: 935 - 938
24. Knegtering H., Lamberts P.A., Prakken G., Ten Brink C (2000) Serum prolactin levels and sexual dysfunction in antipsychotic medication, such as risperidone: a review. Acta Neuropsychiatr 12: 19 - 26
25. Knegtering H., van der Moolen A.E., Castelein S., Kluiter H., van den Bosch R.J. (2003) What are the effects of antipsychotics on sexual dysfunctions and endocrine functioning? Psychoneuroendocrinology 28 (suppl. 2). 109 - 123
26. Knegtering R., Castelein S., Bous H., Van Der Linde J., Bruggeman R., Kluiter H., van den Bosch R.J. (2004) A randomized open-label study of the impact of quetiapine versus risperidone on sexual functioning. J Clin Psychopharmacol 24: 56 - 61
27. Kristensen E. (2002) Sexual side effects of treatment with psychopharmaceuticals. Ugeskr Laeger 164: 4753 - 4756
28. Macdonald S., Halliday J., Macewan T., Sharkey V., Farrington S., Wall S., Mccreadie R.G. (2003) Nithsdale Schizophrenia Surveys 24: sexual dysfunction case - control study. British Journal of Psychiatry 182: 50 - 56
29. Markianos M., Hatzimanolis J., Lykouras L. (1999) Gonadal axis hormones in male schizophrenic patients during treatment with haloperidol and after switch to risperidone. Psychopharmacology (Berl) 143: 270 - 272
30. Meston C.M., Frohlich P.F. (2000) The neurobiology of sexual function. Arch Gen Psychiatry 57: 1012 - 1030
31. Okonmah A.D., Bradshaw W.G., Couceyro P., Soliman K.F. (1986) The effect of neuroleptic drugs on serum testosterone level in the male rat. Gen Pharmacol 17: 235 - 238
32. Perkins D.O. (2002) Predictors of noncompliance in patients with schizophrenia. J Clin Psychiatry 63: 1121 - 8.
33. Pfaus J.G., Phillips A.G. (1991) Role of dopamine in anticipatory and consummatory aspects of sexual behavior in the male rat. Behav Neurosci 105: 727 - 743
34. Ratnasooriya W.D., Ratnayake S.S., Jayatunga Y.N. (2002) Effects of pyrethroid insecticide ICON on reproductive competence of male rats. Asian J Androl 4: 35 - 41
35. Rinieris P., Hatzimanolis J., Markianos M., Stefanis C. (1988) Effects of 4 weeks treatment with chlorpromazine and/or trihexyphenidyl on the pituitary-gonadal axis in male paranoid schizophrenics. Eur Arch Psychiatry Neurol Sci 237 (4). 189 - 193
36. Rinieris P., Hatzimanolis J., Markianos M., Stefanis C. (1989) Effects of treatment with various doses of haloperidol on the pituitary-gonadal axis in male schizophrenic patients. Neuropsychobiology 22: 146 - 149
37. Roman M.D., Carulla S.L., Eroles F.F. (1994) Sexuality and schizophrenia. Acta Psiquiatr Psicol Am Lat 40: 195 - 206
38. Rosenberg K.P., Bleiberg K.L., Koscis J., Gross C. (2003) A survey of sexual side effects among severely mentally ill patients taking psychotropic medications: impact on compliance. J Sex Marital Ther 29 (4). 289 - 296
39. Smith S. (2003) Effects of antipsychotics on sexual and endocrine function in women: implications for clinical practice. J Clin Psychopharmacol 23 (3 suppl. 1). S27 - 32
40. Smith S., Wheeler M.J., Murray R., O'Keane V. (2002 a) The effects of antipsychotic-induced hyperprolactinaemia on the hypothalamic-pituitary-gonadal axis J Clin Psychopharmacol 22: 109 - 114
41. Smith S.M., O'Keane V., Murray R. (2002 b) Sexual dysfunction in patients taking conventional antipsychotic medication. Br J Psychiatry 181: 49 - 55
42. Spollen J.J., Wooten R.G., Cargile C., Bartztokis G. (2004) Prolactin levels and erectile function in patients treated with risperidone. J Clin Psychopharmacol 24: 161 - 166
43. Strange P.G. (2001) Antipsychotic drugs: importance of dopamine receptors for mechanisms of therapeutic actions and side effects. Pharmacol Rev 53: 119 - 133
44. Tupala E., Haapalinna A., Viitamaa T., Mannisto P.T., Saano V. (1999) Effects of repeated low dose administration and withdrawal of haloperidol on sexual behaviour of male rats. Pharmacol Toxicol 84: 292 - 295
45. Wilson C.A., (1993) Pharmacological targets for the control of male and female sexual behaviour. In: Riley A J, Peet M, Wilson C (eds) Sexual Pharmacology. Oxford Medical Publications, Oxford, pp. 1 - 58
46. Wirshing D.A., Pierre J.M., Marder S.R., Saunders C.S., Wirshing W.C. (2002) Sexual side effects of novel antipsychotic medications. Schizophr Res 56: 25 - 30